Capricor Therapeutics, Inc. (CAPR) income statement
CAPRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$7.59+0.06 (+0.80%)
Close on Nov 20, 2026Market cap $441.28MP/E –Yield –
Capricor Therapeutics, Inc. financial ratios
See a number that looks wrong?